News
-
Aclarion Receives Notice of Allowance for US Patent to Support Further Optimization of Accuracy and Reliability in the Nociscan Solution
June 20, 2024 -
Aclarion Announces Updated Product Release That Enhances User-Experience, Scalability, and Security for Nociscan Solution
June 18, 2024 -
Aclarion's Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain
April 25, 2024 -
Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar Discs
March 4, 2024 -
Aclarion Announces Closing of $3.0 Million Public Offering
February 27, 2024 -
Aclarion Announces Pricing of $3.0 Million Public Offering
February 26, 2024 -
Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership
February 5, 2024 -
Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD
January 22, 2024 -
Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan Solution
January 17, 2024 -
Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan
January 8, 2024